Deletion of the deISGylating enzyme USP18 enhances tumour cell antigenicity and radiosensitivity. Pinto-Fernandez A, Salio M, Partridge T, Chen J, et al. Br J Cancer 2021;124:817-830.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Pinto-Fernandez A, Salio M, Partridge T, Chen J, et al. Deletion of the deISGylating enzyme USP18 enhances tumour cell antigenicity and radiosensitivity. Br J Cancer 2021;124:817-830.
PMID: 33214684